8 January 2026
Understanding the 1.4% SEP increase: why the pharmaceutical sector is urging a reconsideration of the price cap.
6 January 2026
Illegal weight loss injections are flooding the local market as high costs and obesity rates drive a dangerous market for GLP-1 agonists.
19 November 2025
Uncover the details of the Hetero price collusion probe as the Competition Commission examines key drug procurement allegations.
19 November 2025
Hetero SA challenges the HIV drug tender decision in court, claiming exclusion from vital antiretroviral supply contracts.
11 November 2025
Examine the ongoing battle over US drug prices and the potential effects of Trump's recent pharma agreements on affordability.
11 November 2025
The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.
5 November 2025
Aspen's Mounjaro expansion plans promise to enhance diabetes and weight management treatment in Sub-Saharan Africa soon.
4 November 2025
Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.
2 November 2025
Spar acquires Aptekor Group to enhance its national pharmacy network and compete in the South African healthcare market.
15 October 2025
Shareholders have approved the Adcock Ingram takeover by Natco Pharma, marking a new chapter for the pharmaceutical company.
7 October 2025
30 September 2025
Explore the urgent call for lenacapavir access, as advocates seek equitable HIV prevention for all communities worldwide.